Topcon Healthcare Launches Customer Care Portal

Leads the Industry in Customer Care, Providing Round-the-Clock Access to Product Information, Technical Support, and Service History

Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched a comprehensive Customer Care Portal.

The Customer Care Portal is available to Topcon Healthcare customers in the U.S., Canada, and Latin America, and can be accessed by visiting support.topconhealthcare.com and registering for a free account.

The portal provides instant access to Topcon support, all in one, secure location. Customers can submit and follow up service requests, download product manuals and user guides, opt in/out of alert notifications, access product maintenance and utilization guidance, contact their salesperson, check order status, and have full visibility to the service history of installed products. A convenient dashboard alerts customers to pending orders and open service cases.

The Topcon Customer Care Portal, a first in the eyecare industry, is built upon the Japanese Omotenashi spirit, which is the act of providing memorable service. “The launch of the portal demonstrates Topcon’s commitment to exceptional customer care. We continue to lead the industry with automation and tools to optimize practice performance,” stated Ali Zendehdel, Vice President of Operations for Topcon Healthcare. “Not only are we at the forefront of technical product innovations, we also lead the way with best-in-class customer support. In addition to the portal, we are expanding our nationwide field service team to provide prompt service to customers in all regions.”

To register for a free account on the Topcon Customer Care Portal, click here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.